|
|
Article: Clinical Study Shows Intramuscular Administration of Aripiprazole (Abilify(R)) Significantly Improves Acute Agitation in Patients With Schizophrenia.
- Article from:
- PR Newswire
- Article date:
- May 5, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Data Show Significant Improvement in Agitation Within 45 Minutes Without Excessive Sedation
Patients with schizophrenia, schizoaffective and schizophreniform disorders who received treatment with intramuscular (IM) administration of aripiprazole (ABILIFY(R)) showed significant improvement in acute agitation as early as 45 minutes after dosing, according to a study presented at the 157th Annual Meeting of the American Psychiatric Association. The study showed that treatment with IM aripiprazole resulted in significant symptom improvement in these patients, and was generally well tolerated, without excessive sedation or pain at the injection site.
...